These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 20068323

  • 1. Apoptosis of oligodendrocytes and post-translational modifications of myelin basic protein in multiple sclerosis: possible role for the early stages of multiple sclerosis.
    Artemiadis AK, Anagnostouli MC.
    Eur Neurol; 2010; 63(2):65-72. PubMed ID: 20068323
    [Abstract] [Full Text] [Related]

  • 2. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA, Harauz G.
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [Abstract] [Full Text] [Related]

  • 3. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
    Itoyama Y, Sternberger NH, Webster HD, Quarles RH, Cohen SR, Richardson EP.
    Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
    [Abstract] [Full Text] [Related]

  • 4. Structural polymorphism and multifunctionality of myelin basic protein.
    Harauz G, Ladizhansky V, Boggs JM.
    Biochemistry; 2009 Sep 01; 48(34):8094-104. PubMed ID: 19642704
    [Abstract] [Full Text] [Related]

  • 5. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG, Moscarello MA.
    J Neurosci Res; 2005 May 01; 80(3):301-8. PubMed ID: 15704220
    [Abstract] [Full Text] [Related]

  • 6. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W.
    Glia; 1999 Oct 01; 28(1):34-9. PubMed ID: 10498820
    [Abstract] [Full Text] [Related]

  • 7. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W, Schmied M, Suchanek G, Brück Y, Breitschopf H, Poser S, Piddlesden S, Lassmann H.
    Ann Neurol; 1994 Jan 01; 35(1):65-73. PubMed ID: 8285595
    [Abstract] [Full Text] [Related]

  • 8. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis.
    Harauz G, Ishiyama N, Hill CM, Bates IR, Libich DS, Farès C.
    Micron; 2004 Jan 01; 35(7):503-42. PubMed ID: 15219899
    [Abstract] [Full Text] [Related]

  • 9. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA.
    Nature; 1990 Jul 12; 346(6280):183-7. PubMed ID: 1694970
    [Abstract] [Full Text] [Related]

  • 10. Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosis.
    Schwab C, McGeer PL.
    Exp Neurol; 2002 Mar 12; 174(1):81-8. PubMed ID: 11869036
    [Abstract] [Full Text] [Related]

  • 11. The distribution of myelin basic protein in central nervous system lesions of multiple sclerosis and acute experimental allergic encephalomyelitis.
    Whitaker JN.
    Ann Neurol; 1978 Apr 12; 3(4):291-8. PubMed ID: 78682
    [Abstract] [Full Text] [Related]

  • 12. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis.
    Mastronardi FG, Mak B, Ackerley CA, Roots BI, Moscarello MA.
    J Clin Invest; 1996 Jan 15; 97(2):349-58. PubMed ID: 8567954
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
    Sinclair C, Mirakhur M, Kirk J, Farrell M, McQuaid S.
    Neuropathol Appl Neurobiol; 2005 Jun 15; 31(3):292-303. PubMed ID: 15885066
    [Abstract] [Full Text] [Related]

  • 14. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N, Chesik D, Hoekstra D, De Keyser J.
    Neurochem Int; 2008 Jun 15; 52(8):1431-5. PubMed ID: 18471934
    [Abstract] [Full Text] [Related]

  • 15. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis.
    Bonetti B, Raine CS.
    Ann Neurol; 1997 Jul 15; 42(1):74-84. PubMed ID: 9225688
    [Abstract] [Full Text] [Related]

  • 16. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
    Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, Sprinkle TJ.
    Lab Invest; 1989 Nov 15; 61(5):489-503. PubMed ID: 2811298
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of the immunohistochemical localization of basic protein to myelin and oligodendrocytes in rat and chicken brain.
    Hartman BK, Agrawal HC, Kalmbach S, Shearer WT.
    J Comp Neurol; 1979 Nov 15; 188(2):273-90. PubMed ID: 91628
    [Abstract] [Full Text] [Related]

  • 18. T-cell vaccination in multiple sclerosis.
    Achiron A, Mandel M.
    Autoimmun Rev; 2004 Jan 15; 3(1):25-32. PubMed ID: 14871646
    [Abstract] [Full Text] [Related]

  • 19. Immunocytochemical method to identify myelin basic protein in oligodendroglia and myelin sheaths of the human nervous system.
    Itoyama Y, Sternberger NH, Kies MW, Cohen SR, Richardson EP, Webster H.
    Ann Neurol; 1980 Feb 15; 7(2):157-66. PubMed ID: 6154439
    [Abstract] [Full Text] [Related]

  • 20. Multiple sclerosis: altered expression of 70- and 27-kDa heat shock proteins in lesions and myelin.
    Aquino DA, Capello E, Weisstein J, Sanders V, Lopez C, Tourtellotte WW, Brosnan CF, Raine CS, Norton WT.
    J Neuropathol Exp Neurol; 1997 Jun 15; 56(6):664-72. PubMed ID: 9184657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.